• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钼靶X线特征与浸润性乳腺癌中的雌激素受体、孕激素受体及人表皮生长因子受体2

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer.

作者信息

Tailaiti Gulijire, Maimaiti Gulanbaier, Aikeremu Youlituzi, Tuerdi Batuer

机构信息

Department of Radiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830000, Xinjiang, People's Republic of China.

出版信息

Int J Gen Med. 2021 Jun 23;14:2777-2783. doi: 10.2147/IJGM.S314055. eCollection 2021.

DOI:10.2147/IJGM.S314055
PMID:34188531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8236255/
Abstract

OBJECTIVE

The aim of this study was to investigate the correlations between molybdenum target X-ray mammography features and the expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in invasive breast cancer (IBC) and their clinical significance.

METHODS

The correlations between the mammographic features and expressions of ER, PR, and HER2 in 378 cases of IBC confirmed by pathology were analyzed retrospectively.

RESULTS

The differences in the ER, PR, and HER2 positive expression between gland types were statistically significant (P < 0.05). The expression of ER was positively correlated with the presence of nipple depression (P < 0.05). Moreover, ER and PR expressions were positively correlated with the absence of axillary lymph node enlargement (P < 0.05) and negatively correlated with the maximum tumor diameter (P < 0.05).

CONCLUSION

The mammographic features of IBC are correlated with the expression of immunity indices ER, PR, and HER2 and reflect several pathological features.

摘要

目的

本研究旨在探讨钼靶X线乳腺摄影特征与浸润性乳腺癌(IBC)中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)表达之间的相关性及其临床意义。

方法

回顾性分析378例经病理确诊的IBC患者的乳腺摄影特征与ER、PR和HER2表达之间的相关性。

结果

不同腺体类型之间ER、PR和HER2阳性表达差异有统计学意义(P < 0.05)。ER表达与乳头凹陷呈正相关(P < 0.05)。此外,ER和PR表达与腋窝淋巴结未肿大呈正相关(P < 0.05),与最大肿瘤直径呈负相关(P < 0.05)。

结论

IBC的乳腺摄影特征与免疫指标ER、PR和HER2的表达相关,并反映了一些病理特征。

相似文献

1
Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer.钼靶X线特征与浸润性乳腺癌中的雌激素受体、孕激素受体及人表皮生长因子受体2
Int J Gen Med. 2021 Jun 23;14:2777-2783. doi: 10.2147/IJGM.S314055. eCollection 2021.
2
[Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].[人羊膜来源的间充质干细胞分化因子对乳腺组织非恶性疾病及非特殊类型浸润性癌生物组织细胞因子产生的影响]
Biomed Khim. 2020 Nov;66(6):485-493. doi: 10.18097/PBMC20206606485.
3
[Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].[雌激素受体、孕激素受体及人表皮生长因子受体2在乳腺癌中的表达及其意义:910例病例分析]
Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3397-400.
4
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer.乳腺癌中多种免疫组化指标的联合检测及临床意义
Mol Clin Oncol. 2013 Jul;1(4):703-710. doi: 10.3892/mco.2013.111. Epub 2013 May 8.
5
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.雌激素或孕激素受体阴性表达在腔面B型HER2阴性乳腺癌患者中的预后价值
World J Surg Oncol. 2016 Sep 13;14(1):244. doi: 10.1186/s12957-016-0999-x.
6
Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use.乳腺癌免疫组织化学特征用于预后评估及治疗的研究
Niger J Surg. 2018 Jul-Dec;24(2):100-106. doi: 10.4103/njs.NJS_2_18.
7
Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.激素受体和人表皮生长因子受体 2 在浸润性乳腺癌中的检测:来自中国 19 个代表性临床中心的 12467 例患者的回顾性研究。
Clin Breast Cancer. 2020 Feb;20(1):e65-e74. doi: 10.1016/j.clbc.2019.07.013. Epub 2019 Aug 23.
8
Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.雌激素受体阴性浸润性乳腺癌:乳腺钼靶表现及其与HER2/neu癌蛋白状态的相关性
Rom J Morphol Embryol. 2012;53(3 Suppl):755-62.
9
Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.在一个多民族亚洲国家中,由雌激素受体、孕激素受体和人类生长因子受体-2所定义的乳腺癌预后情况。
World J Surg. 2015 Oct;39(10):2450-8. doi: 10.1007/s00268-015-3133-2.
10
The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.原发性乳腺癌与同期腋窝淋巴结转移中激素受体和 HER2 状态的病例对照比较。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1559-1565. doi: 10.31557/APJCP.2020.21.6.1559.

引用本文的文献

1
HER-2 expression is correlated with multimodal imaging features in breast cancer: a pilot study.HER-2表达与乳腺癌的多模态成像特征相关:一项初步研究。
Ann Med. 2024 Dec;56(1):2434182. doi: 10.1080/07853890.2024.2434182. Epub 2024 Dec 1.
2
Deep learning modeling using mammography images for predicting estrogen receptor status in breast cancer.使用乳房X光图像进行深度学习建模以预测乳腺癌中的雌激素受体状态。
Am J Transl Res. 2024 Jun 15;16(6):2411-2422. doi: 10.62347/PUHR6185. eCollection 2024.
3
Value of Molybdenum Target X-Ray and High-Frequency Color Doppler Flow Imaging in Early Diagnosis of Breast Carcinoma: A Comparative Analysis.钼靶X线与高频彩色多普勒血流成像在乳腺癌早期诊断中的价值:对比分析
Cancer Manag Res. 2023 Oct 16;15:1155-1163. doi: 10.2147/CMAR.S412924. eCollection 2023.

本文引用的文献

1
[Effect of the primary tumor location on the prognosis of breast invasive ductal carcinoma patients treated with radical mastectomy].[原发肿瘤位置对接受根治性乳房切除术的乳腺浸润性导管癌患者预后的影响]
Zhonghua Zhong Liu Za Zhi. 2019 Sep 23;41(9):686-692. doi: 10.3760/cma.j.issn.0253-3766.2019.09.008.
2
Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.韩国人群中腋窝淋巴结阳性浸润性导管癌分子亚型的肿瘤位置对预后的影响
Breast Cancer Res Treat. 2016 Apr;156(3):473-483. doi: 10.1007/s10549-016-3771-6. Epub 2016 Apr 4.
3
Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.浸润性导管癌患者中Ki-67、雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2/neu(Her2/neu)、p21、表皮生长因子受体(EGFR)和拓扑异构酶II-α(TOP II-α)表达之间的关系及其与预后的相关性。
Asian Pac J Cancer Prev. 2015;16(2):823-9. doi: 10.7314/apjcp.2015.16.2.823.
4
Risk factors for distant metastasis as a primary site of treatment failure in early-stage breast cancer.早期乳腺癌远处转移作为治疗失败主要部位的危险因素。
Chonnam Med J. 2014 Dec;50(3):96-101. doi: 10.4068/cmj.2014.50.3.96. Epub 2014 Dec 17.
5
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.雌激素受体(ER)mRNA 表达与孕激素受体阳性、雌激素受体阴性乳腺癌的分子亚型分布。
Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z. Epub 2013 Dec 15.
6
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
7
Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer.肿瘤发病时间和肿瘤生物学对乳腺癌淋巴结转移的影响。
Springerplus. 2013 Sep 23;2:480. doi: 10.1186/2193-1801-2-480. eCollection 2013.
8
Expressions of ER, PR, HER-2, COX-2, and VEGF in primary and relapsed/metastatic breast cancers.雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER-2)、环氧合酶-2(COX-2)和血管内皮生长因子(VEGF)在原发性及复发/转移性乳腺癌中的表达情况。
Cell Biochem Biophys. 2014 Apr;68(3):511-6. doi: 10.1007/s12013-013-9729-y.
9
Possible influence of mammographic density on local and locoregional recurrence of breast cancer.乳腺钼靶密度对乳腺癌局部及区域复发的潜在影响。
Breast Cancer Res. 2013;15(4):R56. doi: 10.1186/bcr3450.
10
Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.6种常见抗原标志物在乳腺浸润性导管癌中的表达:潜在的临床意义。
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):106-11. doi: 10.1097/PAI.0b013e3181e181b1.